Glenmark Life Sciences Limited(IN:ALIVUS)
₹1,447.60-0.90 (-0.06%)
IN:ALIVUS
Glenmark Life Sciences Limited Revenue
₹1,447.60
At close:-0.90 (-0.06%)
Want to see IN:ALIVUS full AI Analyst Report?
Glenmark Life Sciences Limited (ALIVUS) Revenue
6 Followers
Glenmark Life Sciences Limited Revenue
Glenmark Life Sciences Limited had a revenue of 5.88B in the quarter ending Sep 30, 2024, with -0.11%. This bring the company's revenue in the last twelve months to 11.90B, Decreased 0.05%. In the fiscal year ending Mar 31, 2025, Glenmark Life Sciences Limited had annual revenue of 25.52B with 11.76% growth.
- Revenue (ttm)
- 11.90B
- Revenue Growth
- 8.19%
- P/S Ratio
- 6.98
- Revenue/Employee
- INR 11,231,655
- Employees
- 2,272
- Market Cap
- INR 178.01B
Revenue Chart
Glenmark Life Sciences Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 25.52B | 2.69B | 11.76% |
| Mar 31, 2024 | 22.83B | 1.22B | 5.64% |
| Mar 31, 2022 | 21.61B | 2.76B | 14.64% |
| Mar 31, 2021 | 18.85B | 3.48B | 22.63% |
| Mar 31, 2020 | 15.37B | 15.37B | 619784.27% |
| Mar 31, 2018 | 2.48M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:ALIVUS | 11.90B |
| IN:DIVISLAB | 121.91B |
| IN:GRANULES | 58.83B |
| IN:LAURUSLABS | 78.23B |
| IN:NEULANDLAB | 23.07B |
| IN:SOLARA | 15.35B |

